INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Crestline Management, LP's Holding History (CIK: 0001536054)

Note: Option positions (PUT/CALL) are excluded.

Q2 2018
Shares 31,248 Value ($000) $2,622 Avg Close — Range —